Revance Expands PanOxyl Brand with New Sulfur and Benzoyl Peroxide Acne Treatments
Revance Expands the PanOxyl Brand with New Innovations in Acne Care
Revance has made headlines with the expansion of its renowned PanOxyl skincare line, launching two innovative acne treatments designed to meet the increasing demands of consumers and clinicians alike. On July 28, 2026, the company introduced the Pore Refining Acne Mask and the Acne Clearing Spot Treatment, both of which represent significant advancements in over-the-counter skincare solutions.
New Products to Meet Growing Needs
With an emphasis on high-performance skincare, these products introduce the effective use of sulfur and benzoyl peroxide, two of the most trusted ingredients in acne treatment. The Pore Refining Acne Mask is particularly noteworthy as it marks PanOxyl's entry into the growing sulfur segment. This clinical-grade treatment is formulated with 5% colloidal sulfur, designed to penetrate deep into the pores to tackle blackheads, whiteheads, and excess oil build-up.
The mask leverages a unique blend of Glacial and Kaolin clays which help draw out impurities while minimizing the appearance of pores. Complementing this are nourishing ingredients such as maltobionic acid, bisabolol, and ginger root extracts, all working together to soothe the skin and maintain a healthy skin barrier.
In contrast, the Acne Clearing Spot Treatment builds on PanOxyl's established leadership in the benzoyl peroxide category. With a 10% concentration of benzoyl peroxide, this treatment is formulated to deliver maximum strength in reducing existing blemishes and preventing future breakouts, making it the strongest over-the-counter option available. The formula’s balance of soothing ingredients like allantoin and niacinamide ensures that while users target their blemishes, they also care for their skin, reducing redness and irritation.
Expanding Market Reach
Janelle Wichmann, Chief Marketing Officer for Skincare at Revance, expressed enthusiasm about these product launches, stating,